| 0 |
ANTACID THERAPY |
3 |
0.0231 |
| 1 |
MALIGNANT MELANOMA STAGE 0 |
4 |
0.0191 |
| 2 |
CONGENITAL HIATUS HERNIA |
4 |
0.0175 |
| 3 |
BACTEROIDES INFECTION |
4 |
0.0153 |
| 4 |
SLEEP DISORDER THERAPY |
3 |
0.0152 |
| 5 |
DRUG CHEMICAL INCOMPATIBILITY |
1 |
0.0122 |
| 6 |
INFUSION SITE THROMBOSIS |
3 |
0.0112 |
| 7 |
ANTICOAGULANT THERAPY |
3 |
0.0106 |
| 8 |
APPENDICOLITH |
4 |
0.0103 |
| 9 |
ANALGESIC THERAPY |
3 |
0.0093 |
| 10 |
DRUG THERAPY |
3 |
0.0088 |
| 11 |
BURKHOLDERIA TEST POSITIVE |
1 |
0.0081 |
| 12 |
BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC |
4 |
0.0043 |
| 13 |
TOTAL LUNG CAPACITY DECREASED |
3 |
0.0019 |
| 14 |
CATHETER SITE INFLAMMATION |
1 |
0.0018 |
| 15 |
BLOOD PHOSPHORUS INCREASED |
4 |
0.0015 |
| 16 |
HYPERPHOSPHATAEMIA |
3 |
0.0014 |
| 17 |
AORTIC STENOSIS |
4 |
0.0011 |
| 18 |
LUNG OPACITY |
3 |
0.0011 |
| 19 |
PLEURITIC PAIN |
3 |
0.0011 |
| 20 |
RESTRICTIVE PULMONARY DISEASE |
1 |
0.0009 |
| 21 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
4 |
0.0008 |
| 22 |
SEROMA |
1 |
0.0008 |
| 23 |
BENIGN PROSTATIC HYPERPLASIA |
4 |
0.0008 |
| 24 |
FOREIGN BODY IN RESPIRATORY TRACT |
1 |
0.0008 |
| 25 |
RESPIRATORY SYMPTOM |
2 |
0.0007 |
| 26 |
BLOOD URIC ACID INCREASED |
4 |
0.0007 |
| 27 |
IRON DEFICIENCY |
3 |
0.0007 |
| 28 |
HYPOPHOSPHATAEMIA |
4 |
0.0005 |
| 29 |
RALES |
3 |
0.0005 |
| 30 |
MYASTHENIA GRAVIS |
4 |
0.0005 |
| 31 |
LUNG ABSCESS |
1 |
0.0005 |
| 32 |
BRONCHIECTASIS |
3 |
0.0004 |
| 33 |
APPENDICITIS |
4 |
0.0004 |
| 34 |
OXYGEN CONSUMPTION INCREASED |
1 |
0.0004 |
| 35 |
BREATH SOUNDS ABNORMAL |
2 |
0.0004 |
| 36 |
TROPONIN INCREASED |
3 |
0.0004 |
| 37 |
ASPIRATION |
4 |
0.0004 |
| 38 |
VENTRICULAR FIBRILLATION |
4 |
0.0004 |
| 39 |
BLOOD TEST ABNORMAL |
5 |
0.0004 |
| 40 |
BLOOD CALCIUM INCREASED |
3 |
0.0003 |
| 41 |
SPUTUM DISCOLOURED |
3 |
0.0003 |
| 42 |
HYPERCHOLESTEROLAEMIA |
3 |
0.0003 |
| 43 |
HAEMORRHAGE SUBCUTANEOUS |
1 |
0.0003 |
| 44 |
CARDIOGENIC SHOCK |
4 |
0.0003 |
| 45 |
OBSTRUCTIVE AIRWAYS DISORDER |
3 |
0.0003 |
| 46 |
PULMONARY MASS |
4 |
0.0003 |
| 47 |
MICTURITION URGENCY |
3 |
0.0003 |
| 48 |
ULCER |
4 |
0.0003 |
| 49 |
HYPERLIPIDAEMIA |
3 |
0.0003 |
| 50 |
EXTRAVASATION |
1 |
0.0002 |
| 51 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
4 |
0.0002 |
| 52 |
BLOOD CREATINE INCREASED |
1 |
0.0002 |
| 53 |
GOUT |
4 |
0.0002 |
| 54 |
SUSPECTED OFF LABEL USE |
1 |
0.0002 |
| 55 |
END STAGE RENAL DISEASE |
4 |
0.0002 |
| 56 |
FULL BLOOD COUNT ABNORMAL |
2 |
0.0002 |
| 57 |
LIVER FUNCTION TEST INCREASED |
4 |
0.0002 |
| 58 |
HAEMOPTYSIS |
5 |
0.0002 |
| 59 |
NEURALGIA |
4 |
0.0002 |
| 60 |
BACTERIAL INFECTION |
3 |
0.0002 |
| 61 |
PULMONARY FIBROSIS |
3 |
0.0002 |
| 62 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
4 |
0.0001 |
| 63 |
JOINT INJURY |
3 |
0.0001 |
| 64 |
ASCITES |
4 |
0.0001 |
| 65 |
TRANSAMINASES INCREASED |
3 |
0.0001 |
| 66 |
DUODENAL ULCER PERFORATION |
1 |
0.0001 |
| 67 |
BRONCHOPULMONARY ASPERGILLOSIS |
1 |
0.0001 |
| 68 |
IRON DEFICIENCY ANAEMIA |
1 |
0.0001 |
| 69 |
CORONARY ARTERY DISEASE |
3 |
0.0001 |
| 70 |
UPPER RESPIRATORY TRACT INFECTION |
4 |
0.0001 |
| 71 |
POST PROCEDURAL HAEMORRHAGE |
1 |
0.0001 |
| 72 |
HYPOXIA |
3 |
0.0001 |
| 73 |
CARDIOMEGALY |
1 |
0.0001 |
| 74 |
CARDIOVASCULAR DISORDER |
2 |
0.0001 |
| 75 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
4 |
0.0001 |
| 76 |
HYPONATRAEMIA |
4 |
0.0001 |
| 77 |
LOWER RESPIRATORY TRACT INFECTION |
3 |
0.0001 |
| 78 |
PLEURAL EFFUSION |
4 |
0.0001 |
| 79 |
BLOOD CHOLESTEROL INCREASED |
3 |
0.0001 |
| 80 |
GASTROOESOPHAGEAL REFLUX DISEASE |
5 |
0.0001 |
| 81 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0001 |
| 82 |
TRANSIENT ISCHAEMIC ATTACK |
2 |
0.0001 |
| 83 |
SLEEP DISORDER |
4 |
0.0001 |
| 84 |
ASPARTATE AMINOTRANSFERASE INCREASED |
3 |
0.0001 |
| 85 |
PULMONARY EMBOLISM |
5 |
0.0001 |
| 86 |
DIABETES MELLITUS |
4 |
0.0001 |
| 87 |
THROMBOSIS |
4 |
0.0000 |
| 88 |
DRY MOUTH |
4 |
0.0000 |
| 89 |
PULMONARY HYPERTENSION |
1 |
0.0000 |
| 90 |
BLOOD CREATININE INCREASED |
3 |
0.0000 |
| 91 |
INTENTIONAL PRODUCT MISUSE |
4 |
0.0000 |
| 92 |
MUSCULOSKELETAL STIFFNESS |
4 |
0.0000 |
| 93 |
SWELLING |
4 |
0.0000 |
| 94 |
DRUG INTOLERANCE |
4 |
0.0000 |
| 95 |
LUNG DISORDER |
2 |
0.0000 |
| 96 |
ERECTILE DYSFUNCTION |
1 |
0.0000 |
| 97 |
ABDOMINAL DISTENSION |
4 |
0.0000 |
| 98 |
PNEUMONITIS |
1 |
0.0000 |
| 99 |
SEPSIS |
4 |
0.0000 |
| 100 |
ASTHMA |
4 |
0.0000 |
| 101 |
GENERAL PHYSICAL HEALTH DETERIORATION |
4 |
0.0000 |
| 102 |
SOMNOLENCE |
6 |
0.0000 |
| 103 |
HEART RATE DECREASED |
1 |
0.0000 |
| 104 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 105 |
HYPERGLYCAEMIA |
1 |
0.0000 |
| 106 |
OEDEMA PERIPHERAL |
3 |
0.0000 |
| 107 |
LIVER DISORDER |
1 |
0.0000 |
| 108 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 109 |
GASTROINTESTINAL DISORDER |
2 |
0.0000 |
| 110 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 111 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
4 |
0.0000 |
| 112 |
ABDOMINAL PAIN |
5 |
0.0000 |
| 113 |
ANAEMIA |
4 |
0.0000 |
| 114 |
HYPERTENSION |
4 |
0.0000 |
| 115 |
CONSTIPATION |
4 |
0.0000 |
| 116 |
TREMOR |
3 |
0.0000 |
| 117 |
MEDICATION ERROR |
1 |
0.0000 |
| 118 |
WHEEZING |
1 |
0.0000 |
| 119 |
FEELING HOT |
1 |
0.0000 |
| 120 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 121 |
COUGH |
4 |
0.0000 |
| 122 |
DEVICE MALFUNCTION |
1 |
0.0000 |
| 123 |
ASTHENIA |
5 |
0.0000 |
| 124 |
CONDITION AGGRAVATED |
4 |
0.0000 |
| 125 |
PNEUMONIA |
4 |
0.0000 |
| 126 |
PRODUCT USE IN UNAPPROVED INDICATION |
3 |
0.0000 |
| 127 |
CHEST PAIN |
2 |
0.0000 |
| 128 |
VOMITING |
5 |
0.0000 |
| 129 |
PRODUCT DOSE OMISSION ISSUE |
3 |
0.0000 |
| 130 |
HEART RATE INCREASED |
1 |
0.0000 |
| 131 |
ABDOMINAL PAIN UPPER |
2 |
0.0000 |
| 132 |
PAIN |
4 |
0.0000 |
| 133 |
FATIGUE |
5 |
0.0000 |
| 134 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 135 |
MYALGIA |
1 |
0.0000 |
| 136 |
DEATH |
5 |
0.0000 |
| 137 |
PYREXIA |
2 |
0.0000 |
| 138 |
DRUG INEFFECTIVE |
7 |
0.0000 |
| 139 |
DYSPNOEA |
3 |
0.0000 |
| 140 |
NAUSEA |
4 |
0.0000 |
| 141 |
HYPOTENSION |
1 |
0.0000 |
| 142 |
HEADACHE |
3 |
0.0000 |
| 143 |
OFF LABEL USE |
4 |
0.0000 |
| 144 |
DIZZINESS |
1 |
0.0000 |